Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved It

OSLO, Norway, Sept. 20, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces...

Related Keywords

China ,Oslo ,Norway ,Peking ,Beijing ,Chinese ,Ceophotocure Asaemail ,Jinghe Lang ,Relationsphotocure Asatel ,Linda Wu ,Dan Schneiderpresident ,Prnewswire Photocure ,David Moskowitzvice ,Erik Dahlcfophotocure Asatel ,Anders Neijber ,Corporate Communications Norway Tel ,Academy Member Dr ,Chinese National Medical Products Administration ,Chinese Eugenics Association ,Oslo Stock Exchange ,Cervical Pathology Branch ,Chinese Academy Of Medical Sciences ,Union Medical College Hospital ,Asieris Pharmaceuticals ,Bladder Cancer Company ,Asieris Meditech Co Ltd ,Expert Committee Of Colposcopy ,Academy Member ,Peking Union Medical College Hospital ,Chinese Academy ,Medical Sciences ,Chief Development Officer ,Action Plan ,Eliminate Cervical Cancer ,Healthy China ,Chief Medical ,Global Cancer Statistics ,Chinese Eugenics ,Chinese Journal ,Moskowitzvice President ,Investor Relationsphotocure ,Corporate Communications ,